Abbott Laboratories (ABT): Is This Diabetes Stock a Good Buy?

By Yahoo! Finance | Aug 16, 2024 at 08:53 PM EST

A list of the top diabetes stocks includes Abbott Laboratories, known for its advanced continuous glucose monitoring technology. Despite recent legal issues, analysts maintain a positive outlook with a 14.11% upside potential, emphasizing Abbott's position as a leader in diabetes care solutions.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.